Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Chinese Patent Office
Fish and Richardson
Medtronic
Citi
Covington
Daiichi Sankyo
Cipla
McKesson

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090005

« Back to Dashboard

NDA 090005 describes NAFCILLIN SODIUM, which is a drug marketed by Antibiotice, Apothecon, Aurobindo Pharma Ltd, Istituto Bio Ita Spa, Mylan Labs Ltd, Sagent Pharms, Sandoz, and Watson Labs Inc, and is included in thirteen NDAs. It is available from eight suppliers. Additional details are available on the NAFCILLIN SODIUM profile page.

The generic ingredient in NAFCILLIN SODIUM is nafcillin sodium. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the nafcillin sodium profile page.
Summary for 090005
Tradename:NAFCILLIN SODIUM
Applicant:Istituto Bio Ita Spa
Ingredient:nafcillin sodium
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 090005
Ingredient-typePenicillins
Medical Subject Heading (MeSH) Categories for 090005
Suppliers and Packaging for NDA: 090005
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NAFCILLIN SODIUM nafcillin sodium INJECTABLE;INJECTION 090005 ANDA WG Critical Care, LLC 44567-223 N 44567-223-01
NAFCILLIN SODIUM nafcillin sodium INJECTABLE;INJECTION 090005 ANDA APP Pharmaceuticals, LLC 63323-330 E 63323-330-60

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 10GM BASE/VIAL
Approval Date:Apr 20, 2011TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Moodys
Deloitte
AstraZeneca
Citi
UBS
Accenture
Boehringer Ingelheim
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.